Clemastine/Tamoxifen Hybrids as Easily Accessible Antileishmanial Drug Leads

This article is licensed under aCreative Commons Attribution 3.0 Unported Licence.Victor de Sousa Agostino, Michaela L Buerdsell, Silvia R B Uliana, Paul W Denny, Adriano C Coelho, P. G. Steel Repurposing of drugs is an attractive strategy to accelerate drug discovery. In this context, tamoxifen, a selective oestrogen receptor modulator (SERM) and known anti-breast cancer drug, has been identified as... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Organic and Biomolecular Chemistry - Category: Molecular Biology Authors: Source Type: research